{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T07:07:46Z","timestamp":1793689666804,"version":"4.5.1"},"reference-count":32,"publisher":"MDPI AG","issue":"18","license":[{"start":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T00:00:00Z","timestamp":1757980800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T00:00:00Z","timestamp":1757980800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Introduction: Nasopharyngeal carcinoma (NPC) is a distinct malignancy of the head and neck with high prevalence in endemic regions and a strong association with Epstein\u2013Barr virus (EBV). In locally advanced stages, neoadjuvant chemotherapy (NAC) followed by chemoradiotherapy improves outcomes, but response rates vary. Identifying early predictors of NAC response is essential for guiding personalized treatment strategies. This study aims to assess whether baseline [18F]FDG PET\/CT parameters can predict NAC response in NPC patients. Methods: In this retrospective study, 27 patients with histologically confirmed, locally advanced (stage III) NPC underwent baseline [18F]FDG PET\/CT prior to NAC between 2015 and 2023. Quantitative PET parameters including SUVmax, SUVmean, metabolic tumor volume (MTV), and total lesion glycolysis (TLG) were extracted from the primary tumor. NAC response was assessed using RECIST 1.1 criteria and classified as responders (CR + PR) or non-responders (SD + PD). Group comparisons were performed using Student\u2019s t-test. ROC analysis was used to identify optimal cut-off values. A p-value &lt; 0.05 was considered significant. Results: The cohort included 20 males and 7 females (mean age: 60.8 \u00b1 15.2 years). The predominant histotype was undifferentiated non-keratinizing carcinoma (92.6%). A total of 19 patients (70.4%) responded to NAC. Responders had significantly lower baseline SUVmax (10.9 \u00b1 4.8 vs. 15.8 \u00b1 4.1, p = 0.021), MTV (16.2 \u00b1 12.4 vs. 27.8 \u00b1 19.5 cm3, p = 0.045), and TLG (128.6 \u00b1 98.2 vs. 218.7 \u00b1 152.4, p = 0.038). SUVmean was also lower in responders (6.1 \u00b1 2.1 vs. 9.3 \u00b1 2.8), although not statistically reported. ROC analysis identified SUVmax &gt; 12.5 and MTV &gt; 20.0 cm3 as thresholds associated with poor NAC response. Conclusions: Baseline metabolic parameters from [18F]FDG PET\/CT, particularly SUVmax and MTV, may assist stratification of NAC response in nasopharyngeal carcinoma. These biomarkers may facilitate pre-treatment stratification and guide more personalized therapeutic approaches. However, the limited sample size may affect the generalizability of these findings, and larger prospective studies are needed to confirm the results.<\/jats:p>","DOI":"10.3390\/jcm14186508","type":"journal-article","created":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T14:31:41Z","timestamp":1758033101000},"page":"6508","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Predictive Value of [18F]FDG PET\/CT for Neoadjuvant Chemoradiotherapy Response in Nasopharyngeal Carcinoma"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9845-1384","authenticated-orcid":false,"given":"Natale","family":"Quartuccio","sequence":"first","affiliation":[{"name":"Nuclear Medicine Unit, Ospedali Riuniti Villa Sofia-Cervello, 90146 Palermo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Sireci","sequence":"additional","affiliation":[{"name":"Otorhinolaryngology Section, Department of Precision Medicine in Medical, Surgical and Critical Care (Me.Pre.C.C), University of Palermo, 90133 Palermo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabina","family":"Pulizzi","sequence":"additional","affiliation":[{"name":"Nuclear Medicine Unit, Ospedali Riuniti Villa Sofia-Cervello, 90146 Palermo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Nicolosi","sequence":"additional","affiliation":[{"name":"Nuclear Medicine Unit, Ospedali Riuniti Villa Sofia-Cervello, 90146 Palermo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dante","family":"D\u2019Oppido","sequence":"additional","affiliation":[{"name":"Nuclear Medicine Unit, Ospedali Riuniti Villa Sofia-Cervello, 90146 Palermo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6405-1830","authenticated-orcid":false,"given":"Salvatore","family":"Ialuna","sequence":"additional","affiliation":[{"name":"Nuclear Medicine Unit, Ospedali Riuniti Villa Sofia-Cervello, 90146 Palermo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,9,16]]},"reference":[{"key":"ref_1","first-page":"121","article-title":"An uncommon case of pediatric nasopharyngeal carcinoma with bone metastases and enchondromas evaluated using (18)f-fdg pet\/ct","volume":"33","author":"Quartuccio","year":"2024","journal-title":"Mol. Imaging Radionucl. Ther."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Quartuccio, N., Pulizzi, S., Modica, D.M., Nicolosi, S., D\u2019Oppido, D., Moreci, A.M., and Ialuna, S. (2024). Head-to-head comparison of [(18)f]fdg pet imaging and mri for the detection of recurrence or residual tumor in patients with nasopharyngeal carcinoma: A meta-analysis. Cancers, 16.","DOI":"10.3390\/cancers16173011"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/S0140-6736(15)00055-0","article-title":"Nasopharyngeal carcinoma","volume":"387","author":"Chua","year":"2016","journal-title":"Lancet"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0140-6736(19)30956-0","article-title":"Nasopharyngeal carcinoma","volume":"394","author":"Chen","year":"2019","journal-title":"Lancet"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1200\/JCO.2016.67.4119","article-title":"What is the best treatment of locally advanced nasopharyngeal carcinoma? An individual patient data network meta-analysis","volume":"35","author":"Marguet","year":"2017","journal-title":"J. Clin. Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1002\/ijc.31937","article-title":"Estimating the global cancer incidence and mortality in 2018: Globocan sources and methods","volume":"144","author":"Ferlay","year":"2019","journal-title":"Int. J. Cancer"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.oraloncology.2015.08.005","article-title":"Intensity-modulated radiation therapy versus 2d-rt or 3d-crt for the treatment of nasopharyngeal carcinoma: A systematic review and meta-analysis","volume":"51","author":"Zhang","year":"2015","journal-title":"Oral Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/S1470-2045(16)30410-7","article-title":"Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: A phase 3, multicentre, randomised controlled trial","volume":"17","author":"Sun","year":"2016","journal-title":"Lancet Oncol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1056\/NEJMoa1905287","article-title":"Gemcitabine and cisplatin induction chemotherapy in nasopharyngeal carcinoma","volume":"381","author":"Zhang","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ejca.2016.12.039","article-title":"Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: A phase iii multicentre randomised controlled trial","volume":"75","author":"Cao","year":"2017","journal-title":"Eur. J. Cancer"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1093\/annonc\/mdy249","article-title":"Final results of a randomized phase iii trial of induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in patients with stage iva and ivb nasopharyngeal carcinoma-taiwan cooperative oncology group (tcog) 1303 study","volume":"29","author":"Hong","year":"2018","journal-title":"Ann. Oncol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ejca.2019.07.007","article-title":"Induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: Long-term results of a phase iii multicentre randomised controlled trial","volume":"119","author":"Yang","year":"2019","journal-title":"Eur. J. Cancer"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jns.2018.01.017","article-title":"Preoperative biomarkers in patients with idiopathic normal pressure hydrocephalus showing a favorable shunt surgery outcome","volume":"387","author":"Hong","year":"2018","journal-title":"J. Neurol. Sci."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13014-014-0268-5","article-title":"Pretreatment (18)f-fdg uptake heterogeneity can predict survival in patients with locally advanced nasopharyngeal carcinoma--a retrospective study","volume":"10","author":"Yang","year":"2015","journal-title":"Radiat. Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"884","DOI":"10.2967\/jnumed.113.133801","article-title":"Prognostic value of metabolic tumor volume and total lesion glycolysis in head and neck cancer: A systematic review and meta-analysis","volume":"55","author":"Pak","year":"2014","journal-title":"J. Nucl. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1007\/s00259-018-4065-5","article-title":"What is the prognostic impact of fdg pet in locally advanced head and neck squamous cell carcinoma treated with concomitant chemo-radiotherapy? A systematic review and meta-analysis","volume":"45","author":"Bonomo","year":"2018","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e8084","DOI":"10.1097\/MD.0000000000008084","article-title":"Prognostic value of maximum standard uptake value, metabolic tumor volume, and total lesion glycolysis of positron emission tomography\/computed tomography in patients with nasopharyngeal carcinoma: A systematic review and meta-analysis","volume":"96","author":"Li","year":"2017","journal-title":"Medicine"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"11795549231171793","DOI":"10.1177\/11795549231171793","article-title":"The efficacy of pretreatment (18)f-fdg pet-ct-based deep learning network structure to predict survival in nasopharyngeal carcinoma","volume":"17","author":"Long","year":"2023","journal-title":"Clin. Med. Insights Oncol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"16181","DOI":"10.1002\/cam4.6278","article-title":"A systematic review and meta-analysis of predictive and prognostic models for outcome prediction using positron emission tomography radiomics in head and neck squamous cell carcinoma patients","volume":"12","author":"Philip","year":"2023","journal-title":"Cancer Med."},{"key":"ref_20","first-page":"93","article-title":"The eighth edition ajcc cancer staging manual: Continuing to build a bridge from a population-based to a more \u201cpersonalized\u201d approach to cancer staging","volume":"67","author":"Amin","year":"2017","journal-title":"CA Cancer J. Clin."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"933","DOI":"10.7150\/ijms.105995","article-title":"Pretreatment fdg pet in prognosis of locoregionally advanced nasopharyngeal carcinoma treated with intensity-modulated radiation therapy","volume":"22","author":"Niu","year":"2025","journal-title":"Int. J. Med. Sci."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nature12626","article-title":"Influence of tumour micro-environment heterogeneity on therapeutic response","volume":"501","author":"Junttila","year":"2013","journal-title":"Nature"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1097\/MNM.0000000000000530","article-title":"Non-18f-fdg pet\/ct in the management of patients affected by hnc: State-of-the-art","volume":"37","author":"Quartuccio","year":"2016","journal-title":"Nucl. Med. Commun."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1097\/MNM.0b013e3283495662","article-title":"Clinical utility of 18f-fdg pet parameters in patients with advanced nasopharyngeal carcinoma: Predictive role for different survival endpoints and impact on prognostic stratification","volume":"32","author":"Chan","year":"2011","journal-title":"Nucl. Med. Commun."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"371","DOI":"10.7150\/jca.16732","article-title":"Induction chemotherapy improved long-term outcomes of patients with locoregionally advanced nasopharyngeal carcinoma: A propensity matched analysis of 5-year survival outcomes in the era of intensity-modulated radiotherapy","volume":"8","author":"Peng","year":"2017","journal-title":"J. Cancer"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"4157","DOI":"10.2147\/DDDT.S330154","article-title":"The role of pretreatment (18)f-fdg pet\/ct for early prediction of neoadjuvant chemotherapy response in patients with locoregionally advanced nasopharyngeal carcinoma","volume":"15","author":"Yao","year":"2021","journal-title":"Drug Des. Dev. Ther."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1016\/j.ijrobp.2011.10.023","article-title":"Validation that metabolic tumor volume predicts outcome in head-and-neck cancer","volume":"83","author":"Tang","year":"2012","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"6","DOI":"10.11604\/pamj.2022.41.6.28946","article-title":"Prognostic value of epstein-barr virus DNA load in nasopharyngeal carcinoma: A meta-analysis","volume":"41","author":"Alami","year":"2022","journal-title":"Pan Afr. Med. J."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1007\/s00405-015-3651-4","article-title":"The role of pet\/ct in the management of patients affected by head and neck tumors: A review of the literature","volume":"273","author":"Cammaroto","year":"2016","journal-title":"Eur. Arch. Otorhinolaryngol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"355","DOI":"10.23736\/S1824-4785.19.03192-3","article-title":"Ct radiomics and pet radiomics: Ready for clinical implementation?","volume":"63","author":"Bogowicz","year":"2019","journal-title":"Q. J. Nucl. Med. Mol. Imaging"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"e185","DOI":"10.1002\/mp.13678","article-title":"Machine and deep learning methods for radiomics","volume":"47","author":"Avanzo","year":"2020","journal-title":"Med. Phys."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Cergan, R., Dumitru, M., and Costache, A. (2024). Diagnostic and interventional imaging in various diseases. Medicina, 60.","DOI":"10.3390\/books978-3-7258-2730-5"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/18\/6508\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T12:23:43Z","timestamp":1763727823000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/18\/6508"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,16]]},"references-count":32,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["jcm14186508"],"URL":"https:\/\/doi.org\/10.3390\/jcm14186508","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,16]]}}}